Cyclo Therapeutics, Inc.
CYTHDelisted Mar 26, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000922247
Cyclo Therapeutics, Inc. was delisted on Mar 26, 2025; its insiders filed their last Form 4 on Mar 3, 2025; 22 institutions reported holding it in 13F filings for Q4 2024, worth $1.33M in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding Cyclo Therapeutics, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 14 | 17 | +3 |
| Shares | 456.4K | 481.0K | +24.6K (+5.4%) |
| Value | $725.2K | $682.7K | −$42.4K (−5.8%) |
New holders (4)
Institutions that held Cyclo Therapeutics, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| XTX Topco Ltd | 12,900 | $18.3K | 0.00% |
| Virtu Financial LLC | 10,732 | $15.0K | 0.00% |
| JPMorgan Chase & Co | 240 | $341 | 0.00% |
| UBS Group AG | 88 | $125 | 0.00% |
Sold out (1)
Institutions that held Cyclo Therapeutics, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Renaissance Technologies LLC | 17,800 | $28.0K |